Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: Reappraisal of total pancreatectomy

被引:0
|
作者
Yamaguchi, K [1 ]
Konomi, H [1 ]
Kobayashi, K [1 ]
Gura, Y [1 ]
Sonoda, Y [1 ]
Kawamoto, M [1 ]
Nakano, K [1 ]
Tanaka, M [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Higashi Ku, Fukuoka 8128582, Japan
关键词
total pancreatectomy; intraductal papillary-mucinous tumor;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Total pancreatectomy is rarely performed as the treatment of pancreatic carcinoma because of markedly impaired quality of life and poor prognosis. Intraductal papillary-mucinous tumor (IPMT) of the pancreas is characterized by extensive intraductal spread and favorable outcome even in its invasive stage. The role of total pancreatectomy was reappraised in the treatment of IPMT. Methodology: A total of five Japanese patients with IPMT underwent total pancreatectomy and their clinical follow-up data were reviewed. Results: Total pancreatectomy was performed due to massive involvement of the entire pancreas in two patients, positive surgical margins on frozen section in one, benign IPMT with concomitant pancreatic cancers in one and recurrent IPMT in the remnant pancreas after distal pancreatectomy for IPMT in the other. Three of them underwent total pancreatectomy of the Whipple type, another underwent total gastrectomy and the other underwent the pylorus-preserving method. Surgical margins were negative by histology and no lymph node metastases were evident. Two patients had severe infection including liver abscess in one and pneumonia in the other. The former died on postoperative day 82 and the latter was controlled by medical treatment and discharged on postoperative day 73. The other three patients had an uneventful postoperative course and were discharged from 29 to 62 days after the operation. Longterm follow-up of the four patients revealed that three patients had hypoglycemic attacks, two diabetic retinopathy and two fatty liver. The four patients were doing well from 683 to 4,140 days after the operation without signs of recurrence. Conclusions: Total pancreatectomy would be indicated as a treatment of benign or malignant IPMT with extensive involvement when patients' condition permits and gives a chance of cure, although careful long-term medical care and follow-up are essential.
引用
收藏
页码:1585 / 1590
页数:6
相关论文
共 50 条
  • [31] Are there still indications for total pancreatectomy?
    Del Chiaro, Marco
    Rangelova, Elena
    Segersvard, Ralf
    Arnelo, Urban
    UPDATES IN SURGERY, 2016, 68 (03) : 257 - 263
  • [32] Are there still indications for total pancreatectomy?
    Marco Del Chiaro
    Elena Rangelova
    Ralf Segersvärd
    Urban Arnelo
    Updates in Surgery, 2016, 68 : 257 - 263
  • [33] Are There Indications for Total Pancreatectomy in 2016?
    Andren-Sandberg, Ake
    Ansorge, Christoph
    Yadav, Thakur Deen
    DIGESTIVE SURGERY, 2016, 33 (04) : 329 - 334
  • [34] Proximal subtotal pancreatectomy as an alternative to total pancreatectomy for malnourished patients
    Nakagawa, Yuki
    Kato, Hiroyuki
    Maeda, Koki
    Noguchi, Daisuke
    Gyoten, Kazuyuki
    Hayasaki, Aoi
    Iizawa, Yusuke
    Fujii, Takehiro
    Tanemura, Akihiro
    Murata, Yasuhiro
    Kuriyama, Naohisa
    Kishiwada, Masashi
    Sakurai, Hiroyuki
    Isaji, Shuji
    Mizuno, Shugo
    SURGERY TODAY, 2021, 51 (10) : 1619 - 1629
  • [35] Proximal subtotal pancreatectomy as an alternative to total pancreatectomy for malnourished patients
    Yuki Nakagawa
    Hiroyuki Kato
    Koki Maeda
    Daisuke Noguchi
    Kazuyuki Gyoten
    Aoi Hayasaki
    Yusuke Iizawa
    Takehiro Fujii
    Akihiro Tanemura
    Yasuhiro Murata
    Naohisa Kuriyama
    Masashi Kishiwada
    Hiroyuki Sakurai
    Shuji Isaji
    Shugo Mizuno
    Surgery Today, 2021, 51 : 1619 - 1629
  • [36] Outcome of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas (IPMN): A 10-year Experience
    Marco Niedergethmann
    Robert Grützmann
    Ralf Hildenbrand
    Dag Dittert
    Niloufar Aramin
    Melanie Franz
    Frank Dobrowolski
    Stefan Post
    Hans-Detlev Saeger
    World Journal of Surgery, 2008, 32 : 2253 - 2260
  • [37] Expression of laminin-5-γ-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas
    Fukushima, N
    Sakamoto, M
    Hirohashi, S
    MODERN PATHOLOGY, 2001, 14 (05) : 404 - 409
  • [38] PANCREATIC RESECTION FOR DUCTAL ADENOCARCINOMA - TOTAL PANCREATECTOMY VERSUS PARTIAL PANCREATECTOMY
    FARLEY, DR
    SARR, MG
    VANHEERDEN, JA
    SEMINARS IN SURGICAL ONCOLOGY, 1995, 11 (02): : 124 - 131
  • [39] Intraductal papillary-mucinous tumors:: An entity which is infrequent and difficult to diagnose
    Casado, OA
    Gallardo, DH
    González, EM
    Díaz, MM
    Calvo, AG
    Saborido, BP
    Medina, EM
    Martín, AG
    HEPATO-GASTROENTEROLOGY, 2000, 47 (31) : 275 - 284
  • [40] Immunohistochemical analysis of expression of molecular biologic factors in intraductal papillary-mucinous tumors of pancreas - Diagnostic and biologic significance
    Islam, HK
    Fujioka, Y
    Tomidokoro, T
    Sugiura, H
    Takahashi, T
    Kondo, S
    Katoh, H
    HEPATO-GASTROENTEROLOGY, 1999, 46 (28) : 2599 - 2605